{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T01:39:31Z","timestamp":1761183571011,"version":"build-2065373602"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"am","delay-in-days":304,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22H02781","19K07204","21K06688"],"award-info":[{"award-number":["22H02781","19K07204","21K06688"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.dmpk.2022.100483","type":"journal-article","created":{"date-parts":[[2022,11,5]],"date-time":"2022-11-05T19:56:28Z","timestamp":1667678188000},"page":"100483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Adeno-associated virus-mediated knockdown demonstrates the major role of hepatic Bcrp in the overall disposition of the active metabolite of the tyrosine kinase inhibitor regorafenib in mice"],"prefix":"10.1016","volume":"49","author":[{"given":"Aya Hasan","family":"Alshammari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Masuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shotaro","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiya","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4799-7763","authenticated-orcid":false,"given":"Takahiro","family":"Ishimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-ichi","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8135-5679","authenticated-orcid":false,"given":"Yukio","family":"Kato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2022.100483_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1208\/s12248-014-9668-6","article-title":"Role of the breast cancer resistance protein (BCRP\/ABCG2) in drug transport--an update","volume":"17","author":"Mao","year":"2015","journal-title":"AAPS J"},{"key":"10.1016\/j.dmpk.2022.100483_bib2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.dmpk.2019.12.004","article-title":"Recent progress in in\u00a0vivo phenotyping technologies for better prediction of transporter-mediated drug-drug interactions","volume":"35","author":"Maeda","year":"2020","journal-title":"Drug Metabol Pharmacokinet"},{"key":"10.1016\/j.dmpk.2022.100483_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/mp050113v","article-title":"Breast cancer resistance protein (Bcrp\/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse","volume":"3","author":"Zaher","year":"2006","journal-title":"Mol Pharm"},{"key":"10.1016\/j.dmpk.2022.100483_bib4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1124\/jpet.112.197046","article-title":"Deletion of Abcg2 has differential effects on excretion and pharmacokinetics of probe substrates in rats","volume":"343","author":"Huang","year":"2012","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.dmpk.2022.100483_bib5","first-page":"6447","article-title":"The breast cancer resistance protein (Bcrp1\/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine","volume":"63","author":"van Herwaarden","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.dmpk.2022.100483_bib6","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1093\/carcin\/12.6.1073","article-title":"Fate and distribution of 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) in rats","volume":"12","author":"Watkins","year":"1991","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.dmpk.2022.100483_bib7","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1124\/dmd.108.021410","article-title":"Involvement of multiple transporters in the hepatobiliary transport of rosuvastatin","volume":"36","author":"Kitamura","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.dmpk.2022.100483_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1080\/03602530500364098","article-title":"Knocking down transport: applications of RNA interference in the study of drug transport proteins","volume":"37","author":"Tian","year":"2005","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.dmpk.2022.100483_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41576-019-0205-4","article-title":"Engineering adeno-associated virus vectors for gene therapy","volume":"21","author":"Li","year":"2020","journal-title":"Nat Rev Genet"},{"key":"10.1016\/j.dmpk.2022.100483_bib10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1128\/JVI.79.1.214-224.2005","article-title":"Unrestricted hepatocyte transduction with adeno-associated virus serotype 8 vectors in mice","volume":"79","author":"Nakai","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.dmpk.2022.100483_bib11","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1002\/cam4.883","article-title":"Pharmacologic activity and pharmacokinetics of metabolites of regorafenib in preclinical models","volume":"5","author":"Zopf","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.dmpk.2022.100483_bib12","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s11095-014-1609-7","article-title":"Brain and testis accumulation of regorafenib is restricted by breast cancer resistance protein (BCRP\/ABCG2) and P-glycoprotein (P-GP\/ABCB1)","volume":"32","author":"Kort","year":"2015","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.dmpk.2022.100483_bib13","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.xphs.2017.04.064","article-title":"Involvement of the transporters P-glycoprotein and breast cancer resistance protein in dermal distribution of the multikinase inhibitor regorafenib and its active metabolites","volume":"106","author":"Fujita","year":"2017","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.dmpk.2022.100483_bib14","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.xphs.2019.01.018","article-title":"Influx and efflux transporters contribute to the increased dermal exposure to active metabolite of regorafenib after repeated oral administration in mice","volume":"108","author":"Al-Shammari","year":"2019","journal-title":"J\u00a0Pharmacol Sci"},{"key":"10.1016\/j.dmpk.2022.100483_bib15","article-title":"Species difference in brain penetration of P-gp and BCRP substrates among monkey, dog and mouse","volume":"42","author":"Kido","year":"2021","journal-title":"Drug Metabol Pharmacokinet"},{"key":"10.1016\/j.dmpk.2022.100483_bib16","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/nprot.2006.207","article-title":"Production and characterization of adeno-associated viral vectors","volume":"1","author":"Grieger","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.dmpk.2022.100483_bib17","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1124\/mol.106.026955","article-title":"The important role of Bcrp (Abcg2) in the biliary excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in mice","volume":"70","author":"Zamek-Gliszczynski","year":"2006","journal-title":"Mol Pharmacol"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436722000404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436722000404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:57:05Z","timestamp":1761163025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436722000404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":17,"alternative-id":["S1347436722000404"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2022.100483","relation":{},"ISSN":["1347-4367"],"issn-type":[{"type":"print","value":"1347-4367"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adeno-associated virus-mediated knockdown demonstrates the major role of hepatic Bcrp in the overall disposition of the active metabolite of the tyrosine kinase inhibitor regorafenib in mice","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2022.100483","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100483"}}